{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:00:57Z","timestamp":1789729257778,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4 Part 1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.juro.2015.10.178","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T09:47:19Z","timestamp":1447321639000},"page":"942-948","source":"Crossref","is-referenced-by-count":42,"title":["Tanezumab Reduces Pain in Women with Interstitial Cystitis\/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes"],"prefix":"10.1097","volume":"195","author":[{"given":"J. Curtis","family":"Nickel","sequence":"first","affiliation":[{"name":"Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Mills","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Crook","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria","family":"Jorga","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Smith","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Pfizer Ltd, Tadworth, Surrey, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Krieger","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.10.178_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.eururo.2009.08.005","article-title":"Words of wisdom. Re: Clinical phenotyping in chronic prostatitis\/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes","volume":"56","author":"Nickel","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-133-5-200009050-00013","article-title":"Diagnosis and treatment of chronic abacterial prostatitis: a systematic review","volume":"133","author":"McNaughton Collins","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.juro.2015.10.178_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0090-4295(90)80116-5","article-title":"Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study","volume":"35","author":"Mulholland","year":"1990","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(97)00182-9","article-title":"Hydroxyzine therapy for interstitial cystitis","volume":"49","author":"Theoharides","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.ju.0000132388.54703.4d","article-title":"A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis","volume":"172","author":"van Ophoven","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib6","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/S0002-9343(98)00072-2","article-title":"Recent considerations in nonsteroidal anti-inflammatory drug gastropathy","volume":"105","author":"Singh","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.juro.2015.10.178_bib7","unstructured":"Warner M, Chen LH and Makuc DM: Increase in fatal poisonings involving opioid analgesics in the United States, 1999\u20132006. NCHS data brief, No 22. Hyattsville, Maryland: National Center for Health Statistics. Available at http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db22.pdf. Accessed December 10, 2009."},{"key":"10.1016\/j.juro.2015.10.178_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2006.08.1106","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome and male interstitial cystitis: enigmas and opportunities","volume":"69","author":"Forrest","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib9","first-page":"39","article-title":"Update on urologic pelvic pain syndromes: highlights from the 2010 International Chronic Pelvic Pain Symposium and Workshop, August 29, 2010, Kingston, Ontario, Canada","volume":"13","author":"Nickel","year":"2011","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2005.12.001","article-title":"Novel class of pain drugs based on antagonism of NGF","volume":"27","author":"Hefti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.juro.2015.10.178_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0304-3959(03)00266-5","article-title":"Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity","volume":"105","author":"Delafoy","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.juro.2015.10.178_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/bja\/83.3.442","article-title":"Inflammation of the rat urinary bladder is associated with a referred thermal hyperalgesia which is nerve growth factor dependent","volume":"83","author":"Jaggar","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.juro.2015.10.178_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2982.2003.00427.x","article-title":"Nerve growth factor and gastric hyperalgesia in the rat","volume":"15","author":"Lamb","year":"2003","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.juro.2015.10.178_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1464-410X.1997.00097.x","article-title":"Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis","volume":"79","author":"Lowe","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0090-4295(01)01597-7","article-title":"Nerve growth factor and chronic prostatitis\/chronic pelvic pain syndrome","volume":"59","author":"Miller","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1110\/ps.035402.108","article-title":"Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors","volume":"17","author":"Abdiche","year":"2008","journal-title":"Protein Sci"},{"key":"10.1016\/j.juro.2015.10.178_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jpain.2012.05.006","article-title":"Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase 3 trial","volume":"13","author":"Brown","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.juro.2015.10.178_bib18","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.juro.2010.12.088","article-title":"Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis","volume":"185","author":"Evans","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.pain.2011.05.003","article-title":"Efficacy and safety of tanezumab in the treatment of chronic low back pain","volume":"152","author":"Katz","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.juro.2015.10.178_bib20","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for treatment of knee osteoarthritis pain","volume":"363","author":"Lane","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.10.178_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.urology.2012.07.035","article-title":"Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis\/chronic pelvic pain syndrome","volume":"80","author":"Nickel","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib22","unstructured":"Xie R, Arends R, Olson S et\u00a0al: Preliminary pharmacokinetic\/ pharmacodynamic (PK\/PD) analysis for the effect of tanezumab on overall daily pain score data in adults with moderate-to-severe pain due to osteoarthritis of the knee. Presented at the Population Approach Group in Europe (PAGE), St. Petersburg, Russia, June 23-26, 2009. Available at http:\/\/www.page-meeting.org\/pdf_assets\/7555-PAGE%20Tanezumab%20poster%20_2009.pdf."},{"key":"10.1016\/j.juro.2015.10.178_bib23","unstructured":"Lalovic B, Xie R, Marshall S et\u00a0al: Population PK analysis of tanezumab administered to healthy volunteers subcutaneously or intravenously. Presented at the ASCPT 2010 Annual Meeting, Atlanta, Georgia, November 5\u20139, 2011."},{"key":"10.1016\/j.juro.2015.10.178_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0022-5347(05)68562-X","article-title":"The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network","volume":"162","author":"Litwin","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0090-4295(99)80333-1","article-title":"The interstitial cystitis symptom index and problem index","volume":"49","author":"O\u2019Leary","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.10.178_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.juro.2015.01.037","article-title":"Search for microorganisms in men with urologic chronic pelvic pain syndrome: a culture-independent analysis in the MAPP Research Network","volume":"194","author":"Nickel","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.juro.2009.02.122","article-title":"Clinical phenotyping of women with interstitial cystitis\/painful bladder syndrome: a key to classification and potentially improved management","volume":"182","author":"Nickel","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.juro.2014.07.108","article-title":"Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis\/bladder pain syndrome","volume":"193","author":"Nickel","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.178_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2147\/JPR.S56883","article-title":"The importance of catastrophizing for successful pharmacological treatment of peripheral neuropathic pain","volume":"7","author":"Toth","year":"2014","journal-title":"J Pain Res"},{"key":"10.1016\/j.juro.2015.10.178_bib30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-204905","article-title":"Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain","volume":"74","author":"Schnitzer","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715052167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715052167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.10.178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:05:35Z","timestamp":1651190735000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.10.178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":30,"journal-issue":{"issue":"4 Part 1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1016\/j.juro.2015.10.178"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.10.178","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725944266.793536477","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}